# A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure

> **NCT01241396** · — · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 2396 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Any MMY treatment

## Key facts

- **NCT ID:** NCT01241396
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 2396 (ACTUAL)
- **Last updated:** 2016-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241396, "A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01241396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*